An analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes
An analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes
复制标题
DOI：
10.1093/eurpub/ckt075
复制
发表时间：
2014-06-01
影响因子：
4.4
通讯作者：
McKee, Martin
中科院分区：
文献类型：
--
作者：
Galsworthy, Michael J.;Irwin, Rachel;McKee, Martin
背景资料：以前对欧洲联盟（欧盟）资助的研究的卫生组成部分的分析表明，12个最新成员国（欧盟12国）的项目参与水平较低。此外，缺乏主题领域分析。在欧洲卫生研究项目中，我们筛选了欧盟研究框架方案FP 5和FP 6（1998-2006年）的所有项目，以确定卫生研究项目，并按国家和主题领域描述参与情况。研究方法：FP 5和FP 6项目数据库由编码人员获取和筛选，以确定与健康相关的项目，然后根据欧盟健康门户网站的47个部门（N=2728个项目）加上一组额外的“基础/生物技术”项目（N=1743）进行分类。还分析了项目的国家参与率和协调率。结果：在26946个项目中，约有20%（价值292亿美元）与健康有关（N=4756）。价值（原文如此）60.4亿美元）。在健康类别中，最大的支出是癌症（11.9%）、“其他”（即非精神健康或心血管）非传染性疾病（9.5%）和食品安全（9.4%）。132个国家参加了这些项目。在27个欧盟国家（和5个伙伴国家）中，西北和北欧国家人均获得的项目更多。联合王国牵头协调了超过20%的项目。欧盟12国在参与和协调方面的代表性普遍不足。结论：结合我们的研究结果与相关文献，我们评论的驱动程序决定分布的参与和资金在国家和学科领域。此外，我们还讨论了核心欧盟项目数据库所需的变化，以提供更大的透明度，数据开发和健康研究投资回报。
Background: Previous analyses concerning health components of European Union (EU)-funded research have shown low project participation levels of the 12 newest member states (EU-12). Additionally, there has been a lack of subject-area analysis. In the Health Research for Europe project, we screened all projects of the EU's Framework Programmes for research FP5 and FP6 (1998-2006) to identify health research projects and describe participation by country and subject area. Methods: FP5 and FP6 project databases were acquired and screened by coders to identify health-related projects, which were then categorized according to the 47 divisions of the EU Health Portal (N=2728 projects) plus an extra group of 'basic/biotech' projects (N=1743). Country participation and coordination rates for projects were also analyzed. Results: Approximately 20% of the 26 946 projects (value (sic)29.2bn) were health-related (N=4756. Value (sic)6.04bn). Within the health categories, the largest expenditures were cancer (11.9%), 'other' (i.e. not mental health or cardiovascular) non-communicable diseases (9.5%) and food safety (9.4%). One hundred thirty-two countries participated in these projects. Of the 27 EU countries (and five partner countries), north-western and Nordic states acquired more projects per capita. The UK led coordination with > 20% of projects. EU-12 countries were generally under-represented for participation and coordination. Conclusions: Combining our findings with the associated literature, we comment on drivers determining distribution of participation and funds across countries and subject areas. Additionally, we discuss changes needed in the core EU projects database to provide greater transparency, data exploitation and return on investment in health research.